Health
Researchers urge delaying Pfizer vaccine’s second dose as first highly effective – Reuters
The second dose of Pfizer Inc’s COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based…
By Reuters Staff
(Reuters) – The second dose of Pfizer Incs COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in a letter published in the New England Journal of Medicine.
The vaccine had an efficacy of 92.6% after the first dose, Danuta Skowronski and Gaston De Serres said, based on an analysis of the documents submitted by the drugmaker to the U.S. Food and Drug Administration (FDA).
These findings were…
-
Business12 hours agoWarning! These ASX 200 shares were just downgraded
-
Business9 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General8 hours agoFatal house fire at Lake Illawarra under police investigation
-
Business11 hours agoAfter falling more than 20% on its FY25 result, are Inghams shares a buy the dip opportunity?